Tumor Lysis Syndrome After STI571 in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia-Reference-Cited by-同舟云学术

Tumor Lysis Syndrome After STI571 in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia

Published:2002-01-01 Issue:1 Volume:20 Page:354-355
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Dann Eldad J.¹,Fineman Riva¹,Rowe Jacob M.¹

Affiliation:

1. Rambam Medical Center, Haifa, Israel

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2002.20.1.354

Reference5 articles.

1. Kilic T, Alberta JA, Zdunek PR, et al: Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylaminopyrimidine class. Cancer Res 60: 5143,2000-5150,

2. Buchdunger E, Cioffi CL, Law N, et al: Able protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-Kit and platelet-derived growth factor receptors. J Pharmacol Exp Ther 295: 139,2000-145,

3. Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR–ABL tyrosine kinase

4. Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia

5. Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tyrosine kinase inhibitors and tumor lysis syndrome in hematologic malignancies: A systemic review;European Journal of Haematology;2022-05-24

2. Tumor lysis syndrome: review of pathogenesis, risk factors and management of a medical emergency;Expert Review of Hematology;2016-01-08

3. Simultaneous manifestation of pleural effusion and acute renal failure associated with dasatinib: a case report;Journal of Clinical Pharmacy and Therapeutics;2013-11-05

4. A review of tumour lysis syndrome with targeted therapies and the role of rasburicase;Journal of Clinical Pharmacy and Therapeutics;2011-04-19

5. Renal failure associated with tyrosine kinase inhibitors—Case report and review of the literature;Leukemia Research;2010-01